Table 1 Baseline characteristics between the two study groups
Demographics | Group A (n = 81) | Group B (n = 41) | p value |
|---|---|---|---|
Age, years, mean ± SD | 37 ± 9 | 35 ± 8 | 0.310 |
Male gender | 44 (54.3%) | 23 (56.1%) | 1.000 |
Body weight, kgs, mean ± SD | 54.1 ± 10.3 | 50.8 ± 9.9 | 0.095 |
Baseline CD4 counts, cell/μl, median (IQR) | 29 (8–79) | 19 (8–33) | 0.102 |
Baseline plasma HIV RNA, copies/ml, median (IQR) | 271,500 (95,353–714,000) | 201,000 (73,125–688,500) | 0.269 |
Baseline ALP, U/l, median (IQR) | 85.5 (65.8–126.3) | 93.0 (66.0–141.0) | 0.565 |
Baseline AST, U/l, median (IQR) | 34.0 (25.3–47.8) | 34.0 (21.0–54.0) | 0.636 |
Baseline ALT, U/l, median (IQR) | 32.5 (22.0–48.3) | 28.5 (13.8–52.3) | 0.225 |
Baseline total bilirubin, mg/dl, median (IQR) | 0.5 (0.4–0.7) | 0.6 (0.3–0.8) | 0.561 |